Search Result "suboptimal regimens"
Patients Characteristics and Clinical Implications of Suboptimal CD4 T-Cell Gains After 1 Year of Successful Antiretroviral Therapy
Journal: Current HIV Research
Volume: 6 Issue: 2 Year: 2008 Page: 100-107
Author(s): Felix Gutierrez, Sergio Padilla, Mar Masia, Jose A. Iribarren, Santiago Moreno, Pompeyo Viciana, Jose Hernandez-Quero, Remedios Aleman, Francesc Vidal, Miguel Salavert, Jose R. Blanco, Manuel Leal, Fernando Dronda, Santiago Perez Hoyos, Julia del Amo, CORIS-MD (see appendix)
Suboptimal Etravirine Activity is Common During Failure of Nevirapine-Based Combination Antiretroviral Therapy in a Cohort Infected with Non-B Subtype HIV-1
Journal: Current HIV Research
Volume: 8 Issue: 3 Year: 2010 Page: 194-198
Author(s): Babafemi Taiwo, Beth Chaplin, Sudhir Penugonda, Seema Meloni, Sulaimon Akanmu, Wadzani Gashau, John Idoko, Isaac Adewole, Robert Murphy, Phyllis Kanki
Prospective Evaluation of the Dosing Regimen of Vancomycin in Children of Different Weight Categories
Journal: Current Drug Safety
Volume: 7 Issue: 5 Year: 2012 Page: 375-381
Author(s): Laila Nassar,Salim Hadad,Aharon Gefen,Yael Shachor-Meyouhas,Tatiana Mashiach,Norberto Krivoy,Imad Kassis
Nucleoside-Free Boosted Double PI Regimen: Significant CD4+ T-Cell Recovery in Patients with Poor Immunologic Response Despite Virologic Suppression
Journal: Current HIV Research
Volume: 6 Issue: 6 Year: 2008 Page: 555-559
Author(s): Clara Lehmann, Norma Jung, Anika Hofmann, Oliver A. Cornely, Christoph Wyen, Gerd Fatkenheuer, Pia Hartmann
In Vitro and In Vivo Modeling of Tuberculosis Drugs and its Impact on Optimization of Doses and Regimens
Journal: Current Pharmaceutical Design
Volume: 17 Issue: 2 Year: 2011 Page: 2881-2888
Author(s): Shashikant Srivastava, Tawanda Gumbo
Current and Future Insights in H. pylori Eradication Regimens: The Need of Tailoring Therapy
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 2 Year: 2014 Page: 4521-4532
Author(s): Vasilios Papastergiou, Sotirios D. Georgopoulos, Stylianos Karatapanis
Tuberculosis: An Update on Pathophysiology, Molecular Mechanisms of Drug Resistance, Newer Anti-TB Drugs, Treatment Regimens and Host- Directed Therapies
Journal: Current Topics in Medicinal Chemistry
Volume: 21 Issue: 6 Year: 2021 Page: 547-570
Author(s): Pobitra Borah,Pran K. Deb,Katharigatta N. Venugopala,Nizar A. Al-Sharâi,Vinayak Singh,Satyendra Deka,Amavya Srivastava,Vinod Tiwari,Raghu P. Mailavaram
Long-Term Immunovirogical Effect and Tolerability of a Maraviroc- Containing Regimen in Routine Clinical Practice
Journal: Current HIV Research
Volume: 8 Issue: 6 Year: 2010 Page: 482-486
Author(s): Miguel Genebat, Ezequiel Ruiz-Mateos, Ildefonso Pulido, Alejandro Gonzalez-Serna, Antonio Garcia-Perganeda, Gema Mendez, Maria Concepcion Romero-Sanchez, Sara Ferrando-Martinez, Manuel Leal
Pharmacometrics in Dose Finding or Dose Optimization of Anti-Retroviral and Anti-Tubercular Drugs
Journal: Infectious Disorders - Drug Targets
Volume: 11 Issue: 2 Year: 2011 Page: 157-166
Author(s): Sreedharan Nair Sabarinath, Benjamin Wu, Charles Peloquin, Hartmut Derendorf
Use of Highly Active Antiretroviral Therapy is Increasing in HIV Positive Severe Drug Users
Journal: Current HIV Research
Volume: 8 Issue: 8 Year: 2010 Page: 641-648
Author(s): G. Vallecillo, A. Sanvisens, E. Martinez, M. Torrens, F. Bolao, J. Tor, R. Muga